195 related articles for article (PubMed ID: 38426815)
1. A Pilot Study on Patient-specific Computational Forecasting of Prostate Cancer Growth during Active Surveillance Using an Imaging-informed Biomechanistic Model.
Lorenzo G; Heiselman JS; Liss MA; Miga MI; Gomez H; Yankeelov TE; Reali A; Hughes TJR
Cancer Res Commun; 2024 Mar; 4(3):617-633. PubMed ID: 38426815
[TBL] [Abstract][Full Text] [Related]
2. Prebiopsy multiparametric MRI-based risk score for predicting prostate cancer in biopsy-naive men with prostate-specific antigen between 4-10 ng/mL.
Dwivedi DK; Kumar R; Dwivedi AK; Bora GS; Thulkar S; Sharma S; Gupta SD; Jagannathan NR
J Magn Reson Imaging; 2018 May; 47(5):1227-1236. PubMed ID: 28872226
[TBL] [Abstract][Full Text] [Related]
3. Nine-year Follow-up for a Study of Diffusion-weighted Magnetic Resonance Imaging in a Prospective Prostate Cancer Active Surveillance Cohort.
Henderson DR; de Souza NM; Thomas K; Riches SF; Morgan VA; Sohaib SA; Dearnaley DP; Parker CC; van As NJ
Eur Urol; 2016 Jun; 69(6):1028-33. PubMed ID: 26482887
[TBL] [Abstract][Full Text] [Related]
4. Multiparametric Magnetic Resonance Imaging for Active Surveillance of Prostate Cancer.
An JY; Sidana A; Choyke PL; Wood BJ; Pinto PA; Türkbey İB
Balkan Med J; 2017 Sep; 34(5):388-396. PubMed ID: 28990929
[TBL] [Abstract][Full Text] [Related]
5. Update on Multiparametric Prostate MRI During Active Surveillance: Current and Future Trends and Role of the PRECISE Recommendations.
Giganti F; Kirkham A; Allen C; Punwani S; Orczyk C; Emberton M; Moore CM
AJR Am J Roentgenol; 2021 Apr; 216(4):943-951. PubMed ID: 32755219
[TBL] [Abstract][Full Text] [Related]
6. Progression and treatment rates using an active surveillance protocol incorporating image-guided baseline biopsies and multiparametric magnetic resonance imaging monitoring for men with favourable-risk prostate cancer.
Thurtle D; Barrett T; Thankappan-Nair V; Koo B; Warren A; Kastner C; Saeb-Parsy K; Kimberley-Duffell J; Gnanapragasam VJ
BJU Int; 2018 Jul; 122(1):59-65. PubMed ID: 29438586
[TBL] [Abstract][Full Text] [Related]
7. Low-risk prostate cancer selected for active surveillance with negative MRI at entry: can repeat biopsies at 1 year be avoided? A pilot study.
Olivier J; Kasivisvanathan V; Drumez E; Fantoni JC; Leroy X; Puech P; Villers A
World J Urol; 2019 Feb; 37(2):253-259. PubMed ID: 30039385
[TBL] [Abstract][Full Text] [Related]
8. Multiparametric Magnetic Resonance Imaging Is Associated with Increased Medicare Spending in Prostate Cancer Active Surveillance.
Macleod LC; Yabes JG; Fam MM; Bandari J; Yu M; Maganty A; Furlan A; Filson CP; Davies BJ; Jacobs BL
Eur Urol Focus; 2020 Mar; 6(2):242-248. PubMed ID: 31031042
[TBL] [Abstract][Full Text] [Related]
9. The role of multiparametric magnetic resonance in active surveillance of a low-risk prostate cancer cohort from clinical practice.
Chamorro Castillo L; García Morales L; Ruiz López D; Salguero Segura J; Valero Rosa J; Anglada Curado FJ; Mesa Quesada J; Blanca Pedregosa A; Carrasco Valiente J; Gómez Gómez E
Prostate; 2023 Jun; 83(8):765-772. PubMed ID: 36895160
[TBL] [Abstract][Full Text] [Related]
10. Four-year outcomes from a multiparametric magnetic resonance imaging (MRI)-based active surveillance programme: PSA dynamics and serial MRI scans allow omission of protocol biopsies.
Gallagher KM; Christopher E; Cameron AJ; Little S; Innes A; Davis G; Keanie J; Bollina P; McNeill A
BJU Int; 2019 Mar; 123(3):429-438. PubMed ID: 30113755
[TBL] [Abstract][Full Text] [Related]
11. Prostate Indeterminate Lesions on Magnetic Resonance Imaging-Biopsy Versus Surveillance: A Literature Review.
Gómez Rivas J; Giganti F; Álvarez-Maestro M; Freire MJ; Kasivisvanathan V; Martinez-Piñeiro L; Emberton M
Eur Urol Focus; 2019 Sep; 5(5):799-806. PubMed ID: 29525382
[TBL] [Abstract][Full Text] [Related]
12. Unified model involving genomics, magnetic resonance imaging and prostate-specific antigen density outperforms individual co-variables at predicting biopsy upgrading in patients on active surveillance for low risk prostate cancer.
Beksac AT; Ratnani P; Dovey Z; Parekh S; Falagario U; Roshandel R; Sobotka S; Kewlani D; Davis A; Weil R; Bashorun H; Jambor I; Lewis S; Haines K; Tewari AK
Cancer Rep (Hoboken); 2022 Mar; 5(3):e1492. PubMed ID: 34931468
[TBL] [Abstract][Full Text] [Related]
13. Active Surveillance of Prostate Cancer Using Multiparametric Magnetic Resonance Imaging: A Review of the Current Role and Future Perspectives.
Sklinda K; Mruk B; Walecki J
Med Sci Monit; 2020 Apr; 26():e920252. PubMed ID: 32279066
[TBL] [Abstract][Full Text] [Related]
14. Personalized Decision Making for Biopsies in Prostate Cancer Active Surveillance Programs.
Tomer A; Rizopoulos D; Nieboer D; Drost FJ; Roobol MJ; Steyerberg EW
Med Decis Making; 2019 Jul; 39(5):499-508. PubMed ID: 31319751
[No Abstract] [Full Text] [Related]
15. Value of Serial Multiparametric Magnetic Resonance Imaging and Magnetic Resonance Imaging-guided Biopsies in Men with Low-risk Prostate Cancer on Active Surveillance After 1 Yr Follow-up.
Hamoen EHJ; Hoeks CMA; Somford DM; van Oort IM; Vergunst H; Oddens JR; Smits GA; Bokhorst LP; Witjes JA; Rovers MM; Hulsbergen-van de Kaa CA; Barentsz JO
Eur Urol Focus; 2019 May; 5(3):407-415. PubMed ID: 29331622
[TBL] [Abstract][Full Text] [Related]
16. Multiparametric MRI in detection and staging of prostate cancer.
Boesen L
Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066
[TBL] [Abstract][Full Text] [Related]
17. Stratification of the aggressiveness of prostate cancer using pre-biopsy multiparametric MRI (mpMRI).
Dwivedi DK; Kumar R; Bora GS; Thulkar S; Sharma S; Gupta SD; Jagannathan NR
NMR Biomed; 2016 Mar; 29(3):232-8. PubMed ID: 26730884
[TBL] [Abstract][Full Text] [Related]
18. Outcomes of Serial Multiparametric Magnetic Resonance Imaging and Subsequent Biopsy in Men with Low-risk Prostate Cancer Managed with Active Surveillance.
Hsiang W; Ghabili K; Syed JS; Holder J; Nguyen KA; Suarez-Sarmiento A; Huber S; Leapman MS; Sprenkle PC
Eur Urol Focus; 2021 Jan; 7(1):47-54. PubMed ID: 31147263
[TBL] [Abstract][Full Text] [Related]
19. Multiparametric magnetic resonance imaging facilitates reclassification during active surveillance for prostate cancer.
Fujihara A; Iwata T; Shakir A; Tafuri A; Cacciamani GE; Gill K; Ashrafi A; Ukimura O; Desai M; Duddalwar V; Stern MS; Aron M; Palmer SL; Gill IS; Abreu AL
BJU Int; 2021 Jun; 127(6):712-721. PubMed ID: 33043575
[TBL] [Abstract][Full Text] [Related]
20. The role of MRI in active surveillance for men with localized prostate cancer.
Recabal P; Ehdaie B
Curr Opin Urol; 2015 Nov; 25(6):504-9. PubMed ID: 26372037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
